Cryolife Inc  

(Public, NYSE:CRY)   Watch this stock  
Find more results for cryolife
-0.15 (-0.82%)
May 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 18.20 - 18.35
52 week 11.35 - 20.15
Open 18.20
Vol / Avg. 52,295.00/196,319.00
Mkt cap 602.06M
P/E 59.22
Div/yield 0.03/0.66
EPS 0.31
Shares 33.26M
Beta 1.16
Inst. own 78%
Jul 24, 2017
Q2 2017 CryoLife Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 17, 2017
CryoLife Inc Annual Shareholders Meeting
May 3, 2017
CryoLife Inc at Deutsche Bank Health Care Conference - Webcast
Apr 27, 2017
Q1 2017 CryoLife Inc Earnings Call - Webcast
Apr 26, 2017
Q1 2017 CryoLife Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 4.93% 5.98%
Operating margin 5.65% 12.10%
EBITD margin - 12.36%
Return on average assets 2.81% 4.33%
Return on average equity 4.14% 5.80%
Employees 665 -
CDP Score - -


1655 Roberts Blvd NW
KENNESAW, GA 30144-3632
United States - Map
+1-770-4193355 (Phone)
+1-770-4260031 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Officers and directors

James Patrick Mackin Chairman of the Board, President, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
D. Ashley Lee CPA Chief Financial Officer, Chief Operating Officer, Executive Vice President
Age: 51
Bio & Compensation  - Reuters
James M McDermid Chief Human Resource Officer
Bio & Compensation  - Reuters
John Davis Senior Vice President - Global Sales and Marketing
Age: 51
Bio & Compensation  - Reuters
William Matthews Senior Vice President - Operations, Quality, and Regulatory
Age: 61
Bio & Compensation  - Reuters
Amy D. Horton CPA Chief Accounting Officer
Age: 44
Bio & Compensation  - Reuters
Jean F. Holloway Chief Compliance Officer, Vice President, General Counsel, Secretary
Age: 58
Bio & Compensation  - Reuters
Scott B. Capps Vice President - Clinical Research
Age: 49
Bio & Compensation  - Reuters
David C. Gale Ph.D. Vice President - Research & Development
Age: 48
Bio & Compensation  - Reuters
James Bullock Director
Age: 60
Bio & Compensation  - Reuters